-
1Academic Journal
Source: Ukrainian Journal of Perinatology and Pediatrics; No. 2(90) (2022): Ukrainian Journal of Perinatology and Pediatrics; 17-30
Украинский журнал Перинатология и Педиатрия; № 2(90) (2022): Ukrainian Journal of Perinatology and Pediatrics; 17-30
Український журнал Перинатологія і Педіатрія; № 2(90) (2022): Український журнал Перинатологія і Педіатрія; 17-30Subject Terms: педиатрическое мультисистемное воспаление, ассоциированное с COVID-19, pediatric multisystem inflammatory disease, COVID-19 related, запальне захворювання, асоційоване з COVID-19, педиатрический мультисистемный воспалительный синдром, MIS-C, асоційований з COVID-19, MIS-C, ассоциированный с COVID-19, MIS-C associated with COVID-19, COVID-19, педіатричний синдром мультисистемної відповіді, педіатричне мультисистемне запальне захворювання, PIMS-TS, pediatric inflammatory multisystem syndrome, 3. Good health
File Description: application/pdf
-
2Academic Journal
Authors: Yu. V. Lobzin, A. A. Vilnits, M. M. Kostik, M. K. Bekhtereva, A. N. Uskov, N. V. Skripchenko, I. V. Babachenko, D. O. Ivanov, Yu. S. Alexandrovich, Yu. E. Konstantinova, E. A. Dondurei, A. I. Konev, V. V. Karasev, Ю. В. Лобзин, А. А. Вильниц, М. М. Костик, М. К. Бехтерева, А. Н. Усков, Н. В. Скрипченко, И. В. Бабаченко, Д. О. Иванов, Ю. С. Александрович, Ю. Е. Константинова, Е. А. Дондурей, А. И. Конев, В. В. Карасев
Source: Journal Infectology; Том 13, № 1 (2021); 13-20 ; Журнал инфектологии; Том 13, № 1 (2021); 13-20 ; 2072-6732 ; 10.22625/2072-6732-2021-13-1
Subject Terms: дети, pediatric multisystem inflammatory syndrome associated with SARS-Cov-2, children, педиатрический мультисистемный воспалительный синдром, ассоциированный с SARS-Cov-2
File Description: application/pdf
Relation: https://journal.niidi.ru/jofin/article/view/1173/868; Royal College of Paediatric and Child Health. Guidance: paediatric multisystem inflammatory syndrome temporally associated with COVID-19. https://www.rcpch.ac.uk/resources/guidance-paediatric-multisystem-inflammatory-syndrometemporally-associated-covid-19. Published 2020.; Kelvin, Alyson A., and Scott Halperin. «COVID-19 in children: the link in the transmission chain.» The Lancet Infectious Diseases 20.6 (2020): 633-634.; Leidman, Eva, et al. “COVID-19 trends among persons aged 0–24 years—united states, march 1–december 12, 2020.” Morbidity and Mortality Weekly Report 70.3 (2021): 88.14]; Toubiana J, Poirault C, Corsia A, Bajolle F, Fourgeaud J, Angoulvant F, et al. Kawasaki-like multisystem inflammatory syndrome in children during the covid-19 pandemic in Paris, France: prospective observational study. BMJ. 2020; 369: m2094.; Ravelli A, Minoia F, Davì S, Horne A, Bovis F, Pistorio A, et al. 2016 Classification Criteria for Macrophage ActivationSyndrome Complicating Systemic Juvenile Idiopathic Arthritis: A European League Against Rheumatism/American College of Rheumatology/Paediatric Rheumatology International Trials Organisation Collaborative Initiative. Ann. Rheum. Dis. 2016;75 (3): 481–489.; Брегель, Л.В. Болезнь Кавасаки и мультисистемный воспалительный синдром при инфекции COVID-19 у детей / Л.В. Брегель [и др.] // Педиатрия им. Г.Н. Сперанского. 2020. – № 99 (6). – С. 209–219.; Consiglio, Camila Rosat, et al. «The immunology of multisystem inflammatory syndrome in children with COVID-19.» Cell 183.4 (2020): 968-981.; Verdoni L, Mazza A, Gervasoni A. An outbreak of severe Kawasaki-like disease at the Italian epicentre of the SARSCoV-2 epidemic: an observational cohort study. Lancet. 2020; 395 (10239): 1771–1778.; Daskalakis D. Health Alert# 13: pediatric multi-system inflammatory syndrome potentially associated with COVID-19 //NYC Health. – 2020. [Internet] URL: https://www1.nyc.gov/assets/doh/downloads/pdf/han/alert/2020/covid-19-pediatric-multi-system-inflammatory-syndrome.pdf (data available 24.01.2021); Ahmed, Mubbasheer, et al. “Multisystem inflammatory syndrome in children: A systematic review.” EClinicalMedicine 26 (2020): 100527.1, 16; Особенности клинических проявлений и лечения заболевания, вызванного новой коронавирусной инфекцией (COVID-19), у детей. Методические рекомендации. Версия 2 /Александрович Ю.С., Алексеева Е.И., Бакрадзе М.Д. и др. //Педиатрическая фармакология. 2020; 17 (3): 187–212. doi:10.15690/pf.v17i3.2123; Available from: https://stati0.minzdrav.gov.ru/system/attachments/attaches/000/050/914/original/03062020_дети_COVID-19_v2.pdf; Jindal AK, Pilania RK, Prithvi A, Guleria S, Singh S. Kawasaki disease: characteristics, diagnosis, and unusual presentations. Expert. Rev. Clin. Immunol. 2019; 15 (10): 1089–1104; Whittaker E, Bamford A, Kenny J. Clinical Characteristics of 58 Children With a Pediatric Inflammatory Multisystem Syndrome Temporally Associated With SARSCoV-2. JAMA. 2020; 324 (3): 259–269.; Wu L, O’Kane AM, Peng H, Bi Y, Motriuk-Smith D, Ren J. SARS-CoV-2 and cardiovascular complications: From molecular mechanisms to pharmaceutical management. Biochem. Pharmacol. 2020; 178: 114114; Cuomo A.M., Zucker H.A., Dreslin S. Health advisory: pediatric multi-system inflammatory syndrome potentially associated with сoronavirus disease (COVID-19) children // New York State of Opportunity. Department of Health. – 2020. [Internet] https://www.health.ny.gov/press/releases/2020/docs/2020-05-06_covid19_pediatric_inflammatory_syndrome.pdf (data available 24.01.2021); Kawasaki T. Kawasaki disease. Proc Jpn Acad Ser B Phys Biol Sci. 2006 Apr;82(2):59-71.; Kawasaki T. Kawasaki disease. Int J Rheum Dis. 2014 Jun;17(5):597-600. doi:10.1111/1756-185X.12408.; https://journal.niidi.ru/jofin/article/view/1173